Loading Page
Dr. Mark Boguniewicz, MD is a pediatric allergist and immunologist in Denver, CO specializing in pediatric allergy & immunology. Dr. Mark Boguniewicz, MD is affiliated with HCA HealthOne, National Jewish Health and HCA HealthONE Presbyterian St. Luke's HCA HealthONE Rocky Mountain Children's at Presbyterian St. Luke's.
Asthma
Asthma is a chronic lung disease where the tissue and airways of the lungs become extremely sensitive to certain substances. When these substances are breathed in, the lungs become inflamed. The muscles around the airways tighten and squeeze the lungs, and passages within the lungs swell and tighten. The airways themselves produce mucus, which further clogs the tightened, swollen airways. A person having an asthma attack finds it very difficult to breathe, and a severe attack can even be fatal.
Asthma affects people of all ages, but people with asthma are most often diagnosed as children. Symptoms can include wheezing, a tight feeling in the chest, shortness of breath, and coughing. Some people have mild symptoms all the time, and some people have no symptoms at all, but everyone with asthma is susceptible to occasional severe attacks or flare-ups of symptoms when they are exposed to triggers. Triggers vary widely but can include:
Treatment for most asthma patients involves three steps. Patients learn what their asthma triggers are and avoid them. They take a daily control medication, usually an inhaled corticosteroid, to reduce inflammation in the lungs. Also, they have rescue medication with them at all times to take in case of a severe attack. These quick-acting inhaled medications relax the muscles around the airways and allow the lungs to open up for air.
There is no cure for asthma, but with treatment it should not interfere with daily life and activities.
He completed residency at Children's Hospital of Michigan. He is certified by the Board Certification: Pediatrics and Allergy-Immunology and has a state license in Colorado.
Residency: Children's Hospital of Michigan
Board Certification: Board Certification: Pediatrics and Allergy-Immunology
Licensed In: Colorado
Dr. Mark Boguniewicz, MD does not have any reviews yet, be the first to leave a review of Dr. Mark Boguniewicz, MD here: Leave a Review
These charts describe general payments received by Dr. Mark Boguniewicz, MD. Doctors may receive payments for a number of reasons, including meal compensation, travel compensation, and consulting.
|
$449,419
DUPIXENT DUPILUMAB INJECTION $278,646 |
DUPIXENT $170,772 |
|||||
|
$356,018
DUPIXENT $242,326 |
ATOPIC DERMATITIS - DISEASE $48,484 |
NO PRODUCT DISCUSSED $36,799 |
DISEASE STATE $88 |
$28,320 |
||
|
$203,583
DUPIXENT $54,811 |
DUPIXENT DUPILUMAB INJECTION $30,414 |
$118,358 |
||||
|
$82,173
EBGLYSS $7,845 |
$74,327 |
|||||
|
$74,797
EUCRISA $36,266 |
CIBINQO $14,273 |
Non-Covered Product $340 |
$23,918 |
|||
|
$325,031
DUPIXENT $61,510 |
TAPINAROF $28,985 |
Otezla $14,446 |
OPZELURA $12,675 |
VTAMA $11,412 |
Other $196,004 |
| $747,031 | |
| $418,233 | |
| $282,778 | |
| $28,442 | |
| $13,325 | |
| $1,210 |
Dr. Mark Boguniewicz, MD has received 311 research payments totaling $468,355.
Dr. Mark Boguniewicz is a pediatric allergy & immunology specialist in Denver, CO. His areas of expertise include drug allergy, hay fever (allergic rhinitis), and asthma. For his residency, Dr. Boguniewicz trained at Children's Hospital of Michigan. Awards and/or distinctions he has received include AAAAI Foundation and Donald Y.M. Leung, MD PhD FAAAI-JACI Editors Lectureship; AAAAI’s Bruton Lecture; and Best Doctors in America. He is conversant in Polish. He is affiliated with Children's Hospital Colorado, Rocky Mountain Hospital for Children, and National Jewish Health.
